Company / EPS (Diluted)
Surgery Partners, Inc. EPS (Diluted) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.33
FY2024
5-year range
-$3.19 / -$0.09
FY2020-FY2024
Trend
-1377.8%
vs FY2023
Sector context
#127 of 159
Health Care
What the data says
EPS (Diluted) changed -1378% YoY in FY2024, a notable deviation from the 9-year average annual change of -234%.
Based on SEC 10-K filings.
-1.33 in FY2024.
Declined from $-0.59 to $-1.33 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 159This company -$1.33 Sector average $1.56
▼
-185.4% below sector average
Key checks
Key Insights
- In FY2024, eps (diluted) decreased 1377.8% year-over-year.
- Ranks #127 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.31 (distress zone, below 1.8 threshold)
- Negative profit margin: -14.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.33 | -1377.8% |
| FY2023 | -$0.09 | +84.7% |
| FY2022 | -$0.59 | +47.3% |
| FY2021 | -$1.12 | +64.9% |
| FY2020 | -$3.19 | -39.3% |
| FY2019 | -$2.29 | -332.1% |
| FY2018 | -$0.53 | +7.0% |
| FY2017 | -$0.57 | +72.1% |
| FY2016 | -$2.04 | -628.6% |
| FY2015 | -$0.28 | +86.3% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026